Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026816 · ClinicalTrials.gov registry record · NA
Epidural Stimulation After Neurologic Damage
A NA study of Spinal Cord Injuries and Paraplegia, Complete, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03026816: Recruiting NA study of Spinal Cord Injuries and Paraplegia, Complete, sponsored by University of Minnesota.
NCT03026816 is a NA study of Spinal Cord Injuries and Paraplegia, Complete that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03026816, a NA study of Spinal Cord Injuries and Paraplegia, Complete, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord injury.
Primary Outcome
Brain Motor Control Assessment Volitional Response Index Magnitude
Conditions Studied
Interventions
- DEVICE Epidural Spinal Cord Stimulation
Study Locations (1)
Minnesota
- Hennepin County Medical Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-08-07 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT03026816 shows while recruiting
NCT03026816 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (64% higher).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Epidural Spinal Cord Stimulation is the first listed.
NCT03026816 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03026816 about?
NCT03026816 is a clinical study titled "Epidural Stimulation After Neurologic Damage". This study will evaluate a method to optimize parameter settings in epidural spinal cord stimulation used to recover lower extremity volitional movement. The study will also characterize improvement in autonomic function (such as blood pressure control) and other functions related to spinal cord inj...
What is the current status of trial NCT03026816?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-08-07. Estimated completion is 2028-01.
What conditions does trial NCT03026816 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Paraplegia, Complete.
What interventions are being tested in trial NCT03026816?
The interventions under investigation include: Epidural Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03026816?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03026816 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03026816's enrollment target sits among peer trials
100 32nd of 202 higher than 170 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy